Novo Uses UK Academia To Feed Diabetes Pipeline Despite Brexit Doubts
Executive Summary
Novo Nordisk, which says it still has faith in the UK's life science expertise even in the face of Brexit disruption, plans to establish a new research center at the University of Oxford – but will this be enough to help plump up its lackluster pipeline?